{"id":143944,"date":"2023-04-21T10:23:52","date_gmt":"2023-04-21T14:23:52","guid":{"rendered":"https:\/\/44.250.171.167\/?p=143944"},"modified":"2023-04-21T10:23:54","modified_gmt":"2023-04-21T14:23:54","slug":"brooks-laboratories-ltd-revolutionizes-healthcare-industry-with-groundbreaking-research-and-innovation","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/brooks-laboratories-ltd-revolutionizes-healthcare-industry-with-groundbreaking-research-and-innovation\/","title":{"rendered":"Brooks Laboratories Ltd. Revolutionizes Healthcare Industry with Groundbreaking Research and Innovation!"},"content":{"rendered":"\n<p class=\"has-vivid-cyan-blue-color has-text-color\" style=\"font-size:24px\"><strong>Stock Data:<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table><tbody><tr><td class=\"has-text-align-center\" data-align=\"center\"><strong>Ticker<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\">NSE: BROOKS &amp; BSE:\u00a0533543<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\"><strong>Exchange<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\">NSE &amp; BSE<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\"><strong>Industry<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\">PHARMACEUTICALS &amp; BIOTECHNOLOGY<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h5 class=\"has-vivid-cyan-blue-color has-text-color wp-block-heading\" style=\"font-size:24px\">Price Performance:<\/h5>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table><tbody><tr><td class=\"has-text-align-center\" data-align=\"center\"><strong>Last 5 Days<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\">-1.49%<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\"><strong>YTD<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\">-39.27%<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\"><strong>Last 12 Months<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\">-33.95%<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"has-vivid-cyan-blue-color has-text-color\" style=\"font-size:24px\"><strong>Company Description:<\/strong><\/p>\n\n\n\n<p>Brooks Laboratories Ltd is a contract-based pharmaceutical manufacturing company with a diversified product portfolio that includes dry powder injections, liquid injections, carbapenem dry power injectables, tablets, and oral suspensions used in various therapeutic segments. The company owns two manufacturing plants in Baddi, Himachal Pradesh, and Vadodara, Gujarat, with a total manufacturing capacity of around 31.1 crore units p.a. The company has a highly concentrated customer base with the top five customers contributing approximately 77% of the total revenues in FY21.<\/p>\n\n\n\n<p>The Vadodara plant started commercial production in March 2017, but sales have been slow due to delays in regulatory approvals from different countries. To resolve this issue, the company has entered into two joint ventures with SteriScience Pvt Ltd, controlled by Strides Pharma. The first JV, Brooks Steriscience Ltd, will focus on making the Vadodara plant USFDA compliant, attaining additional regulatory approvals, and adding new products. The second JV, SteriBrooks Penems Pvt Ltd, aims to market the products of Brooks Steriscience Pvt Ltd in the export markets. The company&#8217;s Vadodara unit obtained EU-GMP certification in December 2017, and both of its units are WHO-GMP certified. The company&#8217;s product portfolio finds application in various therapeutic segments such as anti-bacterial, antibiotics, anti-gastric, anti-malarial, and life-saving drugs. The company&#8217;s manufacturing capabilities include dry powder injections, liquid injections, tablets, and oral suspensions with a total capacity of around 31.1 crore units p.a.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"585\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/55a802ae-2830-4c4b-83e0-b9cc4edb2f14-1-1024x585.png\" alt=\"\" class=\"wp-image-143952\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/55a802ae-2830-4c4b-83e0-b9cc4edb2f14-1-1024x585.png 1024w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/55a802ae-2830-4c4b-83e0-b9cc4edb2f14-1-300x171.png 300w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/55a802ae-2830-4c4b-83e0-b9cc4edb2f14-1-768x439.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/55a802ae-2830-4c4b-83e0-b9cc4edb2f14-1-1536x878.png 1536w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/55a802ae-2830-4c4b-83e0-b9cc4edb2f14-1-2048x1171.png 2048w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/55a802ae-2830-4c4b-83e0-b9cc4edb2f14-1-700x400.png 700w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"has-vivid-cyan-blue-color has-text-color\" style=\"font-size:24px\"><strong><strong>Critical Success Factors:<\/strong><\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Brooks Laboratories Ltd (BLL) has several key strengths that make it a competitive player in the pharmaceutical industry. One of its major strengths is its experienced management team. The directors collectively have an industry experience of around two decades each, and they are supported by a team of well-versed professionals. This gives the company a competitive edge as it can leverage the expertise and experience of its management team to make informed decisions and drive growth.<\/li><li>Brooks Laboratories Ltd has been diversifying its business in the B2C segment by launching new products, which requires comparatively higher marketing costs. The company has booked great revenue from these new products, and the revenue is gradually picking up. Expanding the product portfolio can help the company tap into new markets and attract new customers.<\/li><li>Research and development (R&amp;D) are critical for pharmaceutical companies to stay competitive and bring new and innovative products to market. Brooks Laboratories Ltd has a strong focus on R&amp;D, with a team of well-versed professionals having rich experience in their respective fields. This can help the company stay ahead of the curve in terms of product innovation and quality.<\/li><li>The pharmaceutical industry is highly regulated and competitive, and companies often face risks and liabilities associated with the products and their manufacturing. Brooks Laboratories Ltd is engaged in the manufacturing of pharmaceutical formulations and has a presence across various geographies. This can help the company diversify its risk and reduce its dependence on any particular market.<\/li><li>Regular compliance with product and manufacturing quality standards of regulatory authorities is critical for selling products across various geographies. Brooks Laboratories Ltd has received USFDA approval for their Vadodara Plant and has established robust quality management systems to ensure compliance with regulatory requirements. This can help the company maintain a good reputation in the industry and attract more customers.<\/li><\/ul>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"585\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/3eec3032-e659-4097-b20b-7aaa0891482f-1-1024x585.png\" alt=\"\" class=\"wp-image-143953\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/3eec3032-e659-4097-b20b-7aaa0891482f-1-1024x585.png 1024w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/3eec3032-e659-4097-b20b-7aaa0891482f-1-300x171.png 300w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/3eec3032-e659-4097-b20b-7aaa0891482f-1-768x439.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/3eec3032-e659-4097-b20b-7aaa0891482f-1-1536x878.png 1536w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/3eec3032-e659-4097-b20b-7aaa0891482f-1-2048x1171.png 2048w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/3eec3032-e659-4097-b20b-7aaa0891482f-1-700x400.png 700w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"has-vivid-cyan-blue-color has-text-color\" style=\"font-size:24px\"><strong>Key Challenges:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Despite the strengths of Brooks Laboratories Ltd (BLL), there are also risks and concerns that investors should consider. One significant risk is the highly regulated nature of the pharmaceutical industry. The company must comply with stringent quality standards and regulations set by regulatory authorities to manufacture and sell its products. Failure to comply with these regulations could result in legal, financial, and reputational consequences for BLL. Additionally, the industry is highly competitive, with numerous small and large players, which may limit BLL&#8217;s market share and pricing power.<\/li><li>Another concern for BLL is its small scale of operations. While the company has been growing, its revenues remain relatively small, and it operates at a modest level compared to other players in the industry. The operating losses incurred until FY21 were due to a loss-making unit in Vadodara, Gujarat, which was subsequently transferred to Brooks Steriscience Ltd (BSL) in a slump exchange basis, resulting in BLL&#8217;s profitability in FY22. However, the company is still in the process of launching new products and expanding its B2C segment, requiring comparatively higher marketing costs, leading to current operating losses. If BLL cannot effectively grow its operations and increase revenue, it may continue to face financial challenges in the future.<\/li><li>BLL&#8217;s joint ventures with Steriscience Specialties Private Limited also pose a potential risk for the company. While the joint ventures may provide opportunities for BLL to expand its product offerings and reach new markets, they also require funding support from BLL. The requirement of funding support for these joint ventures in the future may impact BLL&#8217;s financial stability and cash flows, particularly if the ventures do not generate the expected revenue or profitability.<\/li><\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Stock Data: Ticker NSE: BROOKS &amp; BSE:\u00a0533543 Exchange NSE &amp; BSE Industry PHARMACEUTICALS &amp; BIOTECHNOLOGY Price Performance: Last 5 Days -1.49% YTD -39.27% Last 12 Months -33.95% Company Description: Brooks Laboratories Ltd is a contract-based pharmaceutical manufacturing company with a diversified product portfolio that includes dry powder injections, liquid injections, carbapenem dry power injectables, tablets, [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":143950,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[6352],"tags":[1115],"class_list":["post-143944","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-research-summary","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/iStock-1218551863.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":141613,"url":"https:\/\/alphastreet.com\/india\/brooks-laboratories-ltd-nse-brooks-ltd-q3-fy23-results-out-total-income-fell-20-yoy\/","url_meta":{"origin":143944,"position":0},"title":"Brooks Laboratories Ltd.(NSE: BROOKS) Ltd. : Q3 FY23 Results Out; Total Income fell 20% YoY","author":"Divyansh_Kasana","date":"February 14, 2023","format":false,"excerpt":"Brooks Laboratories Limited (NSE: BROOKS) is a pharmaceutical contract research and manufacturing services company based in India. It offers a range of products catering to critical care segment in Parental Section, such as Beta Lactam, Cephalosporin and General Dry powder Injectables, Ampoules and Liquid vials, and Dry Syrups and Tablets.\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/f2554663-e025-4606-b5c5-466f917d16fe.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/f2554663-e025-4606-b5c5-466f917d16fe.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/f2554663-e025-4606-b5c5-466f917d16fe.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/f2554663-e025-4606-b5c5-466f917d16fe.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/f2554663-e025-4606-b5c5-466f917d16fe.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/f2554663-e025-4606-b5c5-466f917d16fe.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":147882,"url":"https:\/\/alphastreet.com\/india\/alphagraph-brooks-laboratories-ltd-nse-brooks-q4fy23-results-out-total-income-fell-56-yoy\/","url_meta":{"origin":143944,"position":1},"title":"Alphagraph | Brooks Laboratories Ltd (NSE: BROOKS): Q4FY23 Results Out; Total Income fell 56% YoY.","author":"Divyansh_Kasana","date":"May 31, 2023","format":false,"excerpt":"Brooks Laboratories Ltd is a pharmaceutical manufacturing company that primarily operates on a contract basis. The company specializes in the production of pharmaceutical products on behalf of other companies. As a contract manufacturer, Brooks Laboratories works closely with its clients to manufacture pharmaceuticals based on their specific requirements and formulations.\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/f52f6893-3caa-433c-8edf-b38d145bfd39.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/f52f6893-3caa-433c-8edf-b38d145bfd39.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/f52f6893-3caa-433c-8edf-b38d145bfd39.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/f52f6893-3caa-433c-8edf-b38d145bfd39.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/f52f6893-3caa-433c-8edf-b38d145bfd39.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/f52f6893-3caa-433c-8edf-b38d145bfd39.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":142717,"url":"https:\/\/alphastreet.com\/india\/earnings-brooks-laboratories-ltd-nse-brooks-q3fy23-results-out-total-income-fell-20-yoy\/","url_meta":{"origin":143944,"position":2},"title":"Earnings | Brooks Laboratories Ltd (NSE: BROOKS): Q3FY23 Results Out; Total Income fell 20% YoY","author":"Divyansh_Kasana","date":"February 24, 2023","format":false,"excerpt":"Brooks Laboratories Ltd (NSE: BROOKS) is a pharmaceutical company based in India. The company offers a range of products that include dry powder injections, liquid injections, carbapenem dry power injectables, tablets, and oral suspensions. These products are used in different therapeutic segments, such as anti-bacterial, antibiotics, anti-gastric, anti-malarial, and life-saving\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":152487,"url":"https:\/\/alphastreet.com\/india\/brooks-laboratories-ltd-q1fy24-8-fall-in-revenue\/","url_meta":{"origin":143944,"position":3},"title":"Brooks Laboratories Ltd Q1FY24; 8% fall in Revenue","author":"Divyansh_Kasana","date":"August 10, 2023","format":false,"excerpt":"Brooks Laboratories Ltd is a pharmaceutical manufacturing company primarily working on contract basis. Financial Results: Brooks Laboratories Ltd reported Revenues for Q1FY24 of \u20b915.70 Crores down from \u20b917.12 Crore year on year, a fall of 8.29%. Total Expenses for Q1FY24 of \u20b920.22 Crores down from \u20b928.32 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-605.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-605.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-605.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-605.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-605.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-605.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":136955,"url":"https:\/\/alphastreet.com\/india\/infographic-brooks-labrotories-nse-brooks-q2-results-released-revenue-down-15-74-yoy\/","url_meta":{"origin":143944,"position":4},"title":"Infographic : Brooks Labrotories (NSE : BROOKS) | Q2 Results Released! | Revenue DOWN 15.74% YoY","author":"Divyansh_Kasana","date":"November 18, 2022","format":false,"excerpt":"Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara Gujarat. Both units are cGMP compliant in accordance with national and international standards. The Vadodara facility has been approved by the European Medicines Agency. The company has a wide range\u2026","rel":"","context":"In &quot;Analysis&quot;","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":136962,"url":"https:\/\/alphastreet.com\/india\/infographic-brooks-labrotories-nse-brooks-q1-results-released-revenue-down-23-21-yoy\/","url_meta":{"origin":143944,"position":5},"title":"Infographic : Brooks Labrotories (NSE : BROOKS) | Q1 Results Released! | Revenue DOWN 23.21% YoY","author":"Divyansh_Kasana","date":"November 18, 2022","format":false,"excerpt":"Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara Gujarat. Both units are cGMP compliant in accordance with national and international standards. The Vadodara facility has been approved by the European Medicines Agency. The company has a wide range\u2026","rel":"","context":"In &quot;Analysis&quot;","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/jubilant-pharma.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/143944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=143944"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/143944\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/143950"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=143944"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=143944"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=143944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}